MA- Monitoring-Expired

Back to Dashboard

No. Reference No. Brand Name Generic Name GMP Status Assessment Pathway Application Date Date 1st Assessment Date 2nd Assessment Query Status Time monitor
112663/2018NEUTAS INJECTIONFILGRASTIM APPLIED FOR GMP FULL ASSESSMENT 2018-09-06
Application Date
2020-08-202020-08-312021-06-212,084 days
23145/2019DREZ POWDERIODATED-PROVIDONE&METRONIZADOLE POWDER APPLIED FOR GMP FULL ASSESSMENT 2022-04-05
Round-1
2023-03-132023-03-162024-04-30777 days
3LUBREX-2020LUBREX EYE DROPSCARBOXYMETHYL CELLULOSE SODIUM APPLIED FOR GMP FULL ASSESSMENT 2022-12-12
Round-1
2023-09-012023-12-282024-05-05526 days
48859/2020CLARICIN-500CLARITHROMYCIN GMP CERTIFICATE AVAILABLE FULL ASSESSMENT 2022-06-20
Round-1
2024-03-282024-04-122024-05-05701 days
50141/2021DYGLI M 50/1000SITAGLIPTIN + METFORMIN HCL GMP CERTIFICATE AVAILABLE FULL ASSESSMENT 2022-03-02
Round-1
2022-07-282023-10-312024-04-30811 days
614762/2022VILDARIL M 50/1000VILDAGLIPTIN/ METFORMIN HYDROCHLORIDE GMP CERTIFICATE AVAILABLE FULL ASSESSMENT 2024-03-13
Round-1
2024-03-192024-03-272024-05-0669 days
714763/2022VILDARIL M 50/850VILDAGLIPTIN/ METFORMIN HYDROCHLORIDE GMP CERTIFICATE AVAILABLE FULL ASSESSMENT 2024-03-13
Round-1
2024-03-272024-04-102024-05-0669 days
814765/2022VILDARIL M 50/500VILDAGLIPTIN/ METFORMIN HYDROCHLORIDE GMP CERTIFICATE AVAILABLE FULL ASSESSMENT 2024-03-13
Round-1
2024-03-182024-04-092024-05-0669 days